Scientists find a weak spot in one of the deadliest brain cancers

Researchers have identified a promising new strategy against glioblastoma, one of the most aggressive brain cancers. By blocking a protein called SET, scientists prevented tumor formation in preclinical models and made cancer cells more vulnerable to radiation therapy. The approach works by restoring activity of PP2A, an enzyme that glioblastoma cells suppress to evade treatment. While these early results are encouraging, human clinical trials are needed to confirm whether this strategy is safe and effective for patients. This discovery offers hope for improving outcomes in a cancer with historically poor prognosis.